Department of Medical Science, Ministry of Public Health, WHO International Salmonella and Shigella Centre, National Institute of Health, Bangkok, Thailand.
Foodborne Pathog Dis. 2011 Feb;8(2):203-11. doi: 10.1089/fpd.2010.0626. Epub 2010 Oct 30.
Salmonella enterica serovar Kedougou is among the top 10 serovars reported in northern Thailand. The objective of this study was to identify risk factors associated with Salmonella Kedougou infection in Thailand and to compare the molecular types and antimicrobial resistance with Salmonella Kedougou isolates of human origin from United States and of animal origin from the United Kingdom.
Data from 13,976 Salmonella infections of which 253 were Salmonella Kedougou collected in Thailand between 2002 and 2008 were analyzed by logistic regression. Antimicrobial susceptibility testing and pulsed-field gel electrophoresis (PFGE) were performed on selected Salmonella Kedougou strains causing infections in Thailand (n = 66), and compared to isolates from the United States (n = 5) and the United Kingdom (n = 20).
Logistic analysis revealed season (hot/dry; p = 0.023), region (northern Thailand; p < 0.001), and specimen (stool; p < 0.001) as significant risk factors associated with Salmonella Kedougou infection compared to other nontyphoid Salmonella. Of the Salmonella Kedougou isolates of human origin, 84% exhibited resistance to at least three antimicrobial classes. Three strains recovered from human stool in Thailand were resistant to third-generation cephalosporins: two harbored bla(CTX-M-63) and one bla(CMY-2). PFGE revealed 45 unique clusters. Isolates obtained from humans in Thailand and the United States presented identical PFGE profiles suggesting a travel association, whereas the majority of the animal isolates from United Kingdom clustered separately.
This study reveals Salmonella Kedougou as a major cause of human infections in northern Thailand especially during the hot period and suggests a global spread probably due to travel. The clonal types causing infections in humans differed from those observed in animals in United Kingdom, which suggests the absence of an epidemiological link and could suggest differences in virulence. The high frequency of antimicrobial resistance, including emergence of resistance to fluoroquinolones and third-generation cephalosporins, might pose problems for treatment of infections.
肠炎沙门氏菌血清型凯杜古是泰国报告的前 10 种血清型之一。本研究的目的是确定与泰国沙门氏菌凯杜古感染相关的危险因素,并比较来自美国的人类来源和来自英国的动物来源的沙门氏菌凯杜古分离株的分子类型和抗药性。
对 2002 年至 2008 年期间在泰国收集的 13976 例沙门氏菌感染病例(其中 253 例为沙门氏菌凯杜古)的数据进行逻辑回归分析。对引起泰国感染的选定沙门氏菌凯杜古菌株(66 株)进行抗菌药敏试验和脉冲场凝胶电泳(PFGE)检测,并与来自美国(5 株)和英国(20 株)的分离株进行比较。
逻辑分析显示,与其他非伤寒沙门氏菌相比,季节(热/干期;p=0.023)、地区(泰国北部;p<0.001)和标本(粪便;p<0.001)是沙门氏菌凯杜古感染的显著危险因素。从人类粪便中分离的沙门氏菌凯杜古菌株中,84%至少对三种抗菌药物类别表现出耐药性。从泰国人类粪便中分离出的三株沙门氏菌对第三代头孢菌素耐药:两株携带 bla(CTX-M-63),一株携带 bla(CMY-2)。PFGE 显示 45 个独特的簇。从泰国和美国的人类分离株中获得的分离株具有相同的 PFGE 图谱,提示存在旅行关联,而从英国获得的大多数动物分离株则分别聚类。
本研究揭示了沙门氏菌凯杜古是泰国北部地区人类感染的主要原因,尤其是在炎热时期,并表明这种全球传播可能是由于旅行造成的。引起人类感染的克隆类型与英国动物观察到的类型不同,这表明不存在流行病学联系,也可能表明毒力存在差异。抗菌药物耐药率高,包括氟喹诺酮类和第三代头孢菌素耐药的出现,可能给感染的治疗带来问题。